Back to top

earnings-estimates-revisions: Archive

Zacks Equity Research

Earnings Estimates Rising for Western Digital (WDC): Will It Gain?

Western Digital (WDC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

WDCNegative Net Change

Zacks Equity Research

Why Onto Innovation (ONTO) Might be Well Poised for a Surge

Onto Innovation (ONTO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

ONTONegative Net Change

Zacks Equity Research

Surging Earnings Estimates Signal Upside for Monolithic (MPWR) Stock

Monolithic Power (MPWR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

MPWRNegative Net Change

Zacks Equity Research

JBT (JBTM) Upgraded to Buy: Here's What You Should Know

JBT (JBTM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

JBTMPositive Net Change

Zacks Equity Research

DPM Metals Inc. (DPMLF) Upgraded to Buy: Here's Why

DPM Metals Inc. (DPMLF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

DPMLFNegative Net Change

Zacks Equity Research

What Makes Veris (VRE) a New Buy Stock

Veris (VRE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

VREPositive Net Change

Zacks Equity Research

Similarweb (SMWB) Upgraded to Buy: Here's What You Should Know

Similarweb (SMWB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SMWBPositive Net Change

Zacks Equity Research

All You Need to Know About Constellium (CSTM) Rating Upgrade to Strong Buy

Constellium (CSTM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CSTMNegative Net Change

Zacks Equity Research

Cellectar Biosciences (CLRB) Upgraded to Buy: Here's What You Should Know

Cellectar Biosciences (CLRB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

CLRBNegative Net Change

Zacks Equity Research

Integra (IART) Upgraded to Buy: What Does It Mean for the Stock?

Integra (IART) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

IARTNegative Net Change